title: Effect of selenium compounds on the damage induced by oxysterol on rat arterial walls.
abstract: Wistar rats were fed Se-deficient (0.017 +/- 0.002 mg Se/kg) and Seadequate (0.32 +/- 0.045 Se mg/kg) diets for 12 mo and then were given 5 mg/kg of cholestane-3beta,5alpha,6beta-triol (3-triol), intravenously. Se compounds (Na(2)SeO(3) and ebselen) were supplemented in different doses and times to the Se-deficient rats. Twenty-four hours after 3-triol infusion, the changes in ultrastructures of rat aorta were examined by scanning electron micrography (SEM) and transmission electron micrography (TEM). SEM examinations showed that 3-triol induced diffused injuries on arterial endothelial urfaces of long-term Se-deficient rat, and a large number of holes or craterlike defects were observed. TEM examinations further showed that 3-triol induced swelling, necrosis, and shedding of endothelial cells, which resulted in the destruction of endothelial integrity. Meanwhile, smooth muscle cells proliferated and migrated toward intimae; the breakage of internal elastic lamina benefited the migration of smooth muscle cells. Supplemented with Na(2)SeO(3) (40 microg/kg, 10 d per continuum) and ebselen (20 mg/kg), respectively, exhibited significant protection from damages induced by 3-triol. It seems that protecting mechanisms were different between Na(2)SeO(3) and ebselen. The present investigation gave visual evidence that both injuries induced by cholesterol oxides and the Se nutritional status contributed to the development of atherosclerosis.
authors.affiliation: Department of Chemistry, Huazhong University of Science and Technology, Wuhan, Hubei 430074, People's Republic of China.
authors.forename: Qingzhi
authors.initials: Q
authors.lastname: Wu
authors.forename: Kaixun
authors.initials: K
authors.lastname: Huang
mesh_terms: D000818:Animals; D001158:Arteries / Q000187:drug effects* / Q000473:pathology* / Q000648:ultrastructure; D001393:Azoles / Q000494:pharmacology; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000633:toxicity*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology* / Q000648:ultrastructure; D054833:Isoindoles; D008054:Lipid Peroxides / Q000378:metabolism*; D008297:Male; D008855:Microscopy, Electron, Scanning; D016566:Organoselenium Compounds / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000172:deficiency; D018036:Selenium Compounds / Q000494:pharmacology*
chemical_list: D001393:Azoles; D054833:Isoindoles; D008054:Lipid Peroxides; D016566:Organoselenium Compounds; D018036:Selenium Compounds; C042986:ebselen; D002784:Cholesterol; D012643:Selenium